ISDA

Entry Detail

PDB ID:

4QD6

Keywords:

Transferase/transferase inhibitor

Title:

ITK kinase domain in complex with inhibitor compound

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Spodoptera frugiperda

PDB Version:

Deposition Date:

2014-05-13

Release Date:

2015-01-14

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.45 Å

R-Value Free:

0.26

R-Value Work:

0.20

R-Value Observed:

0.21

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Tyrosine-protein kinase ITK/TSK
Mutations:Y512E
Chain IDs:A, B
Chain Length:266
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:Q08881 Pfam ID:PF07714 EC:2.7.10.2

Ligand Molecules

30T

Primary Citation

Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK).

Trani, G, Barker, J.J, Bromidge, S.M, Brookfield, F.A, Burch, J.D, Chen, Y, Eigenbrot, C, Heifetz, A, Ismaili, M.H, Johnson, A, Krulle, T.M, MacKinnon, C.H, Maghames, R, McEwan, P.A, Montalbetti, C.A, Ortwine, D.F, Perez-Fuertes, Y, Vaidya, D.G, Wang, X, Zarrin, A.A, Pei, Z.Show

Bioorg.Med.Chem.Lett. 24 5818 5823 (2014)

PMID: 25455497 DOI: 10.1016/j.bmcl.2014.10.020

Abstact

Starting from benzylpyrimidine 2, molecular modeling and X-ray crystallography were used to design highly potent inhibitors of Interleukin-2 inducible T-cell kinase (ITK). Sulfonylpyridine 4i showed sub-nanomolar affinity against ITK, was selective versus Lck and its activity in the Jurkat cell-based assay was greatly improved over 2.

Legend

Protein

Chemical

Disease

Primary Citation of related structures